Friday 6 November 2026 Export XNCR’s income statement to Excel — free account

Xencor, Inc.

XNCR Healthcare Biotechnology

Xencor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $125.6 million, up 13.7% from fiscal 2024.

Revenue: +17.5%
EPS: +29.3%
Free cash flow: −52.9%

Quarter to June 2026, against a year earlier

36.11 2.06 +6.05%

Follow XNCR

Alert me

Market cap: $2.5B
P/E: 0.0×
Fwd P/E: −9.9×
Dividend yield: —
F-score: 3/9
Altman Z: 1.73
Beneish M: −2.86
Dividend safety: n/a

Overview

Xencor, Inc. (XNCR) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Xencor, Inc. (XNCR) trades at a P/B ratio of 5.2×. Over the past ten years it has ranged from 0.8× (August 2025) to 9.3× (January 2015); the current reading is higher than 96% of that period. That is above the Biotechnology industry median of 2.0× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/XNCR/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Xencor, Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/XNCR/metrics/pb-ratio">Xencor, Inc. (XNCR) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	1.8×	(19.36%)
FY2024	2.2×	7.80%
FY2023	2.1×	(3.33%)
FY2022	2.1×	(33.36%)
FY2021	3.2×	(26.77%)
FY2020	4.4×	33.05%
FY2019	3.3×	(12.35%)
FY2018	3.7×	10.85%
FY2017	3.4×	2.12%
FY2016	3.3×	(5.93%)

Period	P/B ratio	Change
Jun 2026	2.4×	37.91%
Mar 2026	1.8×	(1.59%)
Dec 2025	1.8×	28.11%
Sep 2025	1.4×	48.33%
39 more quarters	Free account

Against its own ten years

Low 0.8× High 9.3×

Ten-year median 3.1×

Current reading's percentile 99

Company	P/B ratio
RXRX Recursion Pharmaceuticals, Inc. compare	2.1×
BEAM Beam Therapeutics Inc. compare	2.9×
NAMS NewAmsterdam Pharma Company N.V. compare	3.7×
ZLAB Zai Lab Limited Unsponsored ADR compare	4.5×
XNCR Xencor, Inc.	5.2×
MBX MBX Biosciences, Inc. compare	5.7×
RCUS Arcus Biosciences, Inc. compare	6.4×
PHVS Pharvaris N.V. compare	6.4×
ADMA ADMA Biologics Inc compare	6.7×
Biotechnology industry median	2.0×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Xencor, Inc. (XNCR) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on XNCR

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on XNCR

Stockrow Weekly